Douglas Scott

Scientist II, LNP Formulations & Process Development Prime Medicine

Seminars

Wednesday 8th April 2026
Scalable LNP Manufacturing to Advance Prime Editing for Liver Indications
2:45 pm
  • Introduction to Prime Medicine’s universal liver LNP platform and formulation process
  • Establishing scalable and robust unit operations to support GxP-readiness
  • Key features for navigating a successful technology transfer
Douglas Scott Speaker Image